A Pragmatic Pilot Cluster-Randomized Study of Tobacco Screening and Smoking Cessation Program for Community Pharmacies in Japan: FINE Program

Table 3

Backgrounds of smoking patients.

Parameter	Intervention group (FINE program participants) ()	Control group (usual program participants) ()
Mean (SD) age	63.8 (8.17)	58.3 (21.73)	0.426
Male (%)	83.3	50.0	0.193
Antihypertensive drugs (yes: %)	50.0	33.3	0.168
Drugs for treating dyslipidemia	75.0	8.3	0.002
Drugs for diabetes	33.3	8.3	0.029
Inhaled drugs	16.7	8.3	0.018
Smoking status (%)
Traditional cigarettes	91.7	75.0	0.122
Heated-not-burn/electronic tobacco products	0.0	25.0
Both	8.3	0.0
Mean (SD) amount consumed per day
Traditional cigarettes	14.8 (7.08)	12.4 (5.90)	0.423
Heated-not-burn/electronic tobacco products	15.0 (0.00)	9.7 (8.51)	0.642
Mean (SD) duration of smoking in years	36.3 (14.5)	32.4 (22.3)	0.630
Stage of change (%)
Indifference	0.0	0.0	0.504
Precontemplation	33.3	8.3
Contemplation	25.0	33.3
Preparation	33.3	50.0
Unknown	8.3	8.3